Softgel Capsules Market Share, Size, Trends, Industry Analysis Report, 2026 - 2034
REPORT DETAILS
Softgel Capsules Market Summary
The softgel capsules market size was valued at USD 8.51 billion in 2025, growing at a CAGR of 7.96% during 2026–2034. The market growth is primarily fueled by the growing consumer preference for oral dosage forms and increased demand for nutraceuticals and dairy supplements.
Market Statistics
Key Takeaways
- North America holds the largest market revenue share of 36.50% in 2025. The presence of a robust pharmaceutical industry and high consumer adoption of dietary supplements drive the region’s leading market share.
- Asia Pacific is witnessing the highest growth rate at a CAGR of 9.50%. Rising disposable incomes and a rapidly expanding healthcare sector fuel market growth in the region.
- In 2025, the gelatin-based/animal-based segment accounts for a larger market share of 72.0%. The segment’s long-established use and cost-effectiveness in nutraceutical and pharmaceutical products contribute to its leading market position.
- The pregnancy segment is registering the fastest growth at a CAGR of 7.70%, owing to increasing awareness of prenatal nutrition.
- The pharmaceutical companies segment leads the market with 43.0% share in 2025, primarily due to the extensive use of softgel capsules for drug delivery in various therapeutic areas.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Industry Dynamics
- Increased consumer awareness about preventive healthcare has led to increased demand for nutraceuticals and dietary supplements, which typically use softgel capsules as a delivery method.
- The growing emphasis of the pharmaceutical industry on improving drug delivery systems has positioned softgel capsules as the preferred way for encapsulating sensitive compounds and poorly water-soluble drugs.
- The rising applications of softgel capsules in the cosmeceutical sector are projected to provide significant market opportunities.
- Concerns about gelatin sources may present market challenges.
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
What are Softgel Capsules?
Softgel capsules are oral dosage forms made with a soft gelatin or plant-based outer shell containing liquid, semi-solid, or oil-based active ingredients. They are widely used in pharmaceuticals, nutraceuticals, dietary supplements, and cosmeceuticals due to their improved bioavailability, easy swallowing, taste masking, and enhanced ingredient stability compared to traditional tablets and hard capsules. These capsules also enable accurate dosing and efficient delivery of poorly soluble compounds.
The softgel capsules market focuses on the production and distribution of encapsulated dosage forms with a soft, gelatinous outer shell. The increasing consumer preference for oral dosage forms, driven by their ease of administration and enhanced patient compliance, is a significant market growth factor. Furthermore, the rising demand for dietary supplements and nutraceuticals, coupled with the growing geriatric population requiring convenient medication, is boosting the market demand. The market dynamics are further influenced by the pharmaceutical industry’s focus on developing novel drug delivery systems to improve bioavailability and drug efficacy, thereby enhancing market potential.
An overview of softgel capsules market trends reveals a strong emphasis on technological advancements in encapsulation techniques, aiming to improve product stability and shelf life. Additionally, the market is witnessing a surge in the adoption of vegetarian and vegan softgel alternatives, anti-aging supplements catering to the evolving consumer preferences and dietary restrictions. The pharmaceutical and nutraceutical sectors are actively exploring innovative formulations to expand market penetration, while rigorous regulatory standards and quality control measures are shaping the market outlook. These market insights highlight the importance of understanding the intricate interplay between consumer demands, technological innovations, and regulatory environments for a comprehensive market entry assessment.
Difference Between: Softgel Capsules vs Tablets vs Hard Capsules
| Parameter | Softgel Capsules | Tablets | Hard Capsules |
| Absorption | Generally faster absorption due to liquid or oil-based formulations and improved dissolution of active ingredients | May have slower dissolution depending on compression and coating | Moderate absorption; depends on capsule shell and fill material |
| Ease of Swallowing | Easy to swallow due to smooth, flexible, and streamlined shell design | Can be difficult for some consumers due to size and hardness | Easier than tablets but may feel less smooth compared to softgels |
| Taste Masking | Excellent taste and odor masking through sealed gelatin/plant-based shell | Requires coatings or excipients for effective taste masking | Provides moderate taste masking; shell separates ingredients from mouth |
| Stability | Offers good protection for sensitive oils and moisture-sensitive ingredients, but may require controlled storage | Generally high physical stability and longer shelf life | Good stability, though moisture sensitivity can affect shell integrity |
| Formulation Flexibility | High flexibility for liquids, oils, suspensions, and poorly soluble compounds | Limited mainly to powdered or compressed ingredients | Suitable for powders, granules, and some semi-solid formulations |
| Consumer Preference | Preferred for supplements, vitamins, and oils due to convenience, quick release, and premium feel | Widely preferred for cost-effectiveness and large-scale pharmaceutical use | Popular due to versatility, easy manufacturing, and familiarity |
Softgel Capsules Market Dynamics
Increasing Demand for Dietary Supplements and Nutraceuticals
The growing consumer awareness regarding preventive healthcare and wellness has significantly propelled the market demand for dietary supplements and nutraceuticals, which frequently utilize softgel capsules as a preferred delivery method. This surge is observed across various demographics, with a particular emphasis on the aging population seeking to maintain health and vitality. Softgel capsules offer convenient consumption, accurate dosing, improved ingredient stability, and enhanced absorption of oil-based nutrients. The increasing demand for vitamins, omega-3 supplements, herbal extracts, and other functional ingredients is consequently supporting market expansion.
Enhanced Bioavailability and Drug Delivery
The pharmaceutical industry’s continuous pursuit of improved drug delivery systems has positioned softgel capsules as a preferred choice for encapsulating poorly water-soluble drugs and sensitive compounds. Softgel technology can improve bioavailability, protect active ingredients from degradation, and support more consistent drug absorption and efficacy. In 2025, the U.S. FDA’s Center for Drug Evaluation and Research approved 46 novel drugs, demonstrating the continued expansion of pharmaceutical innovation and the need for adaptable formulation technologies. The growing pipeline of complex drug molecules is therefore encouraging manufacturers to invest in advanced lipid-based formulations and specialized softgel delivery platforms. (Source: fda.gov)
Growing Geriatric Population and Chronic Disease Management
The global aging population is a significant demographic trend influencing the pharmaceutical landscape. Older adults often require multiple medications and dietary supplements to manage chronic conditions. In June 2025, the U.S. Census Bureau reported that the country’s population aged 65 and older had increased by 3.1% to 61.2 million. This demographic expansion is strengthening demand for convenient and easy-to-swallow dosage forms that can support treatment adherence. Softgel capsules are particularly suitable for older consumers due to their smooth texture, accurate dosing, and ability to encapsulate both medicines and nutritional ingredients. (Source: census.gov)
Source: Polaris Market Research Analysis
Segment Insights
Market Assessment – By Type
The market, by type, is segmented into gelatin-based/animal-based and non-animal-based. The gelatin-based/animal-based segment holds a larger softgel capsules market share of 72.0% in 2025, primarily due to its long-established use and cost-effectiveness in pharmaceutical and nutraceutical applications. The widespread availability of gelatin, coupled with its proven track record in encapsulating various formulations, contributes to its dominant position. Furthermore, the established manufacturing infrastructure and existing regulatory frameworks surrounding gelatin-based softgels facilitate their continued prevalence in the market. The industry's familiarity with gelatin's properties and processing methods further reinforces its leading role in the overall market dynamics.
The non-animal-based segment is experiencing the highest growth rate at a CAGR of 9.52%, driven by the increasing demand for vegetarian and vegan alternatives. Consumer preferences are shifting toward plant-derived and non-animal-based products, reflecting a broader trend toward ethical and sustainable consumption. This surge is further fueled by advancements in encapsulation technology, enabling the development of high-quality, stable non-animal-based softgels. The market's responsiveness to evolving consumer demands and dietary restrictions is significantly contributing to the rapid expansion of this subsegment, demonstrating strong market potential.
Market Evaluation – By Application
The market, by application, is segmented into antacid & anti-flatulent preparation, anti-anemic preparations, anti-inflammatory drugs, antibiotic & antibacterial drugs, cough & cold preparations, health supplement such as Liver heatlh supplement and Urolory supplement, vitamin & dietary supplement, and pregnancy. The vitamin & dietary supplement segment is expected to witness 8.77% CAGR. This dominance is attributed to the widespread consumer adoption of vitamin and dietary supplements for preventative health and wellness. The ease of consumption and perceived efficacy of softgel capsules in delivering these supplements has solidified their position within this application area. The growing emphasis on personal health management and the increasing availability of diverse vitamin and dietary formulations further contribute to the dominance of the segment.
The pregnancy segment is witnessing 7.70% CAGR. This surge is primarily driven by the increasing awareness of prenatal nutrition and the essential role of specific vitamins and minerals during pregnancy. The market's responsiveness to the specialized nutritional needs of pregnant women, through the development of tailored softgel formulations, has significantly contributed to its expansion. The rising emphasis on maternal health and the growing number of prescribed prenatal supplements are key factors propelling the growth of this application segment.
Market Evaluation – By End Use
By end use, the market is segmented into pharmaceutical companies, nutraceutical companies, cosmeceutical companies, and contract manufacturing organizations. The pharmaceutical companies segment holds the largest market share of 43.0% in 2025, driven by the extensive use of softgel capsules for drug delivery in various therapeutic areas. The established manufacturing infrastructure and rigorous quality control processes within pharmaceutical companies ensure the production of high-quality softgel capsules. The demand for encapsulated medications, particularly for poorly soluble drugs and sensitive compounds, solidifies the pharmaceutical sector's leading position. This segment's dominance reflects the critical role of softgel capsules in modern drug delivery systems.
Contract manufacturing organizations are experiencing the highest growth rate at a CAGR of 8.19%. This expansion is attributed to the increasing trend of outsourcing manufacturing processes to specialized organizations. The rising demand for customized softgel formulations and the need for cost-effective production have fueled the growth of contract manufacturing organizations. These organizations offer flexibility and expertise in producing diverse softgel capsules, catering to the specific requirements of pharmaceutical, nutraceutical, and cosmeceutical companies. The ability to streamline production and reduce overhead costs has significantly propelled the growth of this segment.
Source: Polaris Market Research Analysis
Regional Analysis
The market exhibits significant regional variations, influenced by factors such as healthcare infrastructure, regulatory environments, and consumer preferences. North America and Europe have established markets, driven by advanced pharmaceutical and nutraceutical industries. The Asia Pacific market is experiencing rapid growth, fueled by increasing healthcare awareness and rising disposable incomes. Latin America and the Middle East & Africa are also showing promising market potential, with growing healthcare expenditures and expanding pharmaceutical sectors. Each region presents unique market dynamics, requiring tailored strategies for successful market penetration.
In 2025, North America holds the largest share of 36.50% in the softgel capsules market revenue, characterized by a robust pharmaceutical industry and high consumer adoption of dietary supplements. The region's advanced healthcare infrastructure and stringent regulatory standards foster a favorable environment for the production and distribution of high-quality softgel capsules. The established presence of major pharmaceutical and nutraceutical companies, coupled with a high awareness of preventive healthcare, contributes to the region's dominant market position. The strong emphasis on innovative drug delivery systems and the widespread availability of diverse softgel formulations further solidify North America's leading role.
The Asia Pacific market is experiencing the highest growth rate at a CAGR of 9.50%, driven by a rapidly expanding healthcare sector and increasing disposable incomes. The growing awareness of preventive healthcare, coupled with rising demand for dietary supplements and nutraceuticals, is fueling market expansion. The region's large and aging population, coupled with increasing chronic disease prevalence, necessitates convenient dosage forms such as softgel capsules. Furthermore, the rising investments in pharmaceutical research and development and the establishment of advanced manufacturing facilities contribute to the region's rapid market growth. The increasing accessibility of healthcare services and the growing middle-class population are key factors propelling the market dynamic.
Source: Polaris Market Research Analysis
Key Players and Competitive Insights
A few key players active in the softgel capsules market include Aenova Holding GmbH; Best Formulations; CAPTEK Softgel International, Inc.; Catalent, Inc.; Fuji Capsule Co., Ltd.; Ourvita; Procaps Group S.A.; Robinson Pharma, Inc.; SIRIO Pharma Co., Ltd.; Soft Gel Technologies, Inc.; Thermo Fisher Scientific Inc.
These companies offer a range of softgel capsule solutions, from formulation and manufacturing to packaging and distribution, catering to the pharmaceutical, nutraceutical, and cosmeceutical sectors.
Competitive analysis of the softgel capsules market reveals a landscape characterized by both established multinational corporations and specialized contract manufacturing organizations. The market is driven by innovation in encapsulation technologies, product diversification, and strategic partnerships. Companies are focusing on expanding their product portfolios to include vegetarian and vegan softgel alternatives, as well as developing advanced drug delivery systems. The competitive environment is further influenced by stringent regulatory standards and the need for high-quality, reliable softgel solutions. Market players are also engaging in strategic acquisitions and collaborations to enhance their manufacturing capabilities and expand their global presence.
Catalent, Inc., headquartered in Somerset, New Jersey, US, provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. Their offerings include a wide range of softgel capsule formulations, manufacturing services, and packaging solutions. They are relevant to the market due to their extensive capabilities in developing and producing softgel capsules for various applications, including pharmaceuticals and nutraceuticals.
List of Key Companies
- Aenova Holding GmbH
- Best Formulations
- CAPTEK Softgel International, Inc.
- Catalent, Inc.
- Fuji Capsule Co., Ltd.
- Ourvita
- Procaps Group S.A.
- Robinson Pharma, Inc.
- SIRIO Pharma Co., Ltd.
- Soft Gel Technologies, Inc.
- Thermo Fisher Scientific Inc.
Softgel Capsules Market Industry Developments
- May 2026: Lotus Pharmaceutical Co., Ltd. announced the global launch of its Nintedanib soft gel capsules (100mg and 150mg). The launch of Nintedanib had expanded to 30 markets across the world. (Source: lotuspharm.com)
What is the Future of the Softgel Capsules Market?
The future growth of the market is driven by the rising preventive healthcare awareness. Growing demand for nutraceuticals, dietary supplements, and advanced oral drug delivery solutions will also boost the market expansion. There are rising Innovations in vegetarian and plant-based softgels, personalized nutrition, and high-bioavailability formulations. They are expected to create lucrative market opportunities. Surging adoption across pharmaceutical, wellness, and cosmeceutical industries will strengthen the role of softgel capsules as a preferred dosage form globally.
Softgel Capsules Market Segmentation
By Type Outlook (Revenue-USD Billion, 2021–2034)
- Gelatin-Based/Animal-Based
- Non-Animal-Based
By Application Outlook (Revenue-USD Billion, 2021–2034)
- Antacid & Anti-Flatulent Preparation
- Anti-Anemic Preparations
- Anti-Inflammatory Drugs
- Antibiotic & Antibacterial Drugs
- Cough & Cold Preparations
- Health Supplement
- Vitamin & Dietary Supplement
- Pregnancy
By End Use Outlook (Revenue-USD Billion, 2021–2034)
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organizations
By Regional Outlook (Revenue-USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Softgel Capsules Market Report Scope
| Report Attributes | Details |
| Market Size Value in 2025 | USD 8.51 billion |
| Market Size Value in 2026 | USD 9.16 billion |
| Revenue Forecast by 2034 | USD 16.96 billion |
| CAGR | 7.96% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2025–2034 |
| Quantitative Units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Insights |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Source: Polaris Market Research Analysis
How is the report valuable for an organization?
Workflow/Innovation Strategy
The softgel capsules market has been segmented on the basis of type, application, and end use. Moreover, the study provides the reader with a detailed understanding of the different segments at both the global and regional levels.
Market Entry Strategies
The softgel capsules market growth strategies emphasize innovation and market penetration. Companies are focusing on developing advanced encapsulation technologies, including vegetarian and vegan softgel alternatives, to cater to evolving consumer preferences. Expanding product portfolios to include specialized formulations for nutraceuticals and pharmaceuticals is crucial. Strategic partnerships and collaborations with research institutions and pharmaceutical companies enhance product development and market reach. Furthermore, targeted marketing campaigns that highlight the benefits of softgel capsules, such as improved bioavailability and ease of consumption, are essential for driving market demand. Companies are also investing in expanding their manufacturing capabilities to meet the growing global demand.
softgel capsules market FAQ's
The market size was valued at USD 8.51 billion in 2025 and is projected to grow to USD 16.96 billion by 2034.
The market is projected to register a CAGR of 7.96% during the forecast period.
North America holds the largest market revenue share of 36.50% in 2025.
A few key players active in the market are Aenova Holding GmbH; Best Formulations; CAPTEK Softgel International, Inc.; Catalent, Inc.; Fuji Capsule Co., Ltd.; Ourvita; Procaps Group S.A.; Robinson Pharma, Inc.; SIRIO Pharma Co., Ltd.; Soft Gel Technologies, Inc.; Thermo Fisher Scientific Inc.
The pharmaceutical companies segment leads the market with 43.0% share in 2025.
Following are a few of the market trends: ? Increased Demand for Vegetarian and Vegan Softgels: A shift toward plant-based alternatives is driving the adoption of non-animal-based softgel capsules. ? Focus on Enhanced Bioavailability: Innovations in encapsulation technologies are aimed at improving drug absorption and efficacy. ? Growing Nutraceutical and Dietary Supplement Market: The rising awareness of preventive healthcare is boosting the demand for softgel-encapsulated vitamins and supplements.
Softgel capsules are oral dosage forms consisting of a soft, gelatin-based (or vegetarian alternative) outer shell that encloses a liquid or semi-solid fill. This encapsulation method is widely used in the pharmaceutical, nutraceutical, and cosmeceutical industries to deliver various active ingredients, including medications, vitamins, and dietary supplements. Softgels are favored for their ease of swallowing, ability to mask unpleasant tastes or odors, and capability to enhance the bioavailability of certain substances, particularly oil-based or poorly water-soluble compounds. They provide a convenient and effective way to administer precise dosages, ensuring patient compliance and product stability.
Download Sample Report of softgel capsules market
Please fill out the form to request a customized copy of the research report.
